These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29869303)

  • 1. Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.
    Benchabane S; Belkhelfa M; Belguendouz H; Zidi S; Boudjelida A; Youinou P; Touil-Boukoffa C
    Inflammopharmacology; 2018 Oct; 26(5):1165-1174. PubMed ID: 29869303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sjögren's syndrome.
    Benchabane S; Belguendouz H; Behairi N; Arroul-Lammali A; Boudjelida A; Youinou P; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):126-133. PubMed ID: 29303022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
    Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS
    Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients.
    Sthoeger Z; Sharabi A; Asher I; Zinger H; Segal R; Shearer G; Elkayam O; Mozes E
    Clin Immunol; 2018 Jul; 192():85-91. PubMed ID: 29730433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-dihydroxyvitamin D3 regulates t helper and b lymphocyte responses substantially in drug-naive primary Sjögren’s syndrome patients’ mononuclear cells.
    Genç D; Sezer Kürkçü M; Günaydın B; Tarhan EF
    Turk J Med Sci; 2021 Oct; 51(5):2467-2476. PubMed ID: 34118806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
    Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
    Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
    Liu TT; Zeng XP; Gu ML; Deng AM
    Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
    Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
    Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of Th17 response by IL-38 in primary Sjögren's syndrome.
    Luo D; Chen Y; Zhou N; Li T; Wang H
    Mol Immunol; 2020 Nov; 127():107-111. PubMed ID: 32950755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.
    Bikker A; van Woerkom JM; Kruize AA; van der Wurff-Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2012 Dec; 71(12):1934-41. PubMed ID: 22563027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the relationship between oxidative stress status and inflammatory markers during primary Sjögren's syndrome: A new approach for patient monitoring.
    Benchabane S; Sour S; Zidi S; Hadjimi Z; Nabila L; Acheli D; Bouzenad A; Belguendouz H; Touil-Boukoffa C
    Int J Immunopathol Pharmacol; 2024; 38():3946320241263034. PubMed ID: 38901876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trained Immunity in Primary Sjögren's Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype.
    Huijser E; van Helden-Meeuwsen CG; Grashof DGB; Tarn JR; Brkic Z; Huisman JMA; Wahadat MJ; van de Werken HJG; Lopes AP; van Roon JAG; van Daele PLA; Kamphuis S; Ng WF; Bekkering S; Joosten LAB; Dik WA; Versnel MA
    Front Immunol; 2022; 13():840751. PubMed ID: 35860283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammation enhances NGF-β/TrkA system expression via EGFR/MEK/ERK pathway activation in Sjögren's syndrome.
    Lisi S; Sisto M; Ribatti D; D'Amore M; De Lucro R; Frassanito MA; Lorusso L; Vacca A; Lofrumento DD
    J Mol Med (Berl); 2014 May; 92(5):523-37. PubMed ID: 24557415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
    Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
    Front Immunol; 2019; 10():2096. PubMed ID: 31552042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome.
    Boumba D; Skopouli FN; Moutsopoulos HM
    Br J Rheumatol; 1995 Apr; 34(4):326-33. PubMed ID: 7788146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():701656. PubMed ID: 34413853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential interleukin (IL)-10 and IL-13 gene expression in vivo in salivary glands and peripheral blood mononuclear cells from patients with primary Sjögren's syndrome.
    Villarreal GM; Alcocer-Varela J; Llorente L
    Immunol Lett; 1996 Jan; 49(1-2):105-9. PubMed ID: 8964596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of M1/M2 macrophage polarization in primary Sjogren's syndrome.
    Chen X; Zhu L; Wu H
    Arthritis Res Ther; 2024 May; 26(1):101. PubMed ID: 38745331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paeoniflorin down-regulates ATP-induced inflammatory cytokine production and P2X7R expression on peripheral blood mononuclear cells from patients with primary Sjögren's syndrome.
    Yu J; Chen Y; Li M; Gao Q; Peng Y; Gong Q; Zhang Z; Wu X
    Int Immunopharmacol; 2015 Sep; 28(1):115-20. PubMed ID: 26049028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo immunomodulatory effect of ethanolic extract of propolis during Celiac Disease: involvement of nitric oxide pathway.
    Medjeber O; Touri K; Rafa H; Djeraba Z; Belkhelfa M; Boutaleb AF; Arroul-Lammali A; Belguendouz H; Touil-Boukoffa C
    Inflammopharmacology; 2018 Dec; 26(6):1469-1481. PubMed ID: 29516252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.